Nuzenio

Replimune Lead Drug

Replimune Lead Drug news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 11 publisher sources 100/100 entity strength

Latest news

FDA Approves Replimune Skin Cancer Drug After Rejections - MedscapeMedscape · Fri, 07 Aug 2026 13:27:22 GMTReplimune Group, Inc. (REPL) Shareholder/Analyst Call - Slideshow (NASDAQ:REPL) 2026-08-07 - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 10:32:36 GMTFDA Approves Replimune’s Melanoma Drug on Third Attempt - WSJWSJ · Thu, 06 Aug 2026 20:46:00 GMTBragar Eagel & Squire, P.C. is Investigating Replimune - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 21:52:17 GMTREPL SHAREHOLDER ALERT: Replimune Group Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - Business WireBusiness Wire · Wed, 05 Aug 2026 00:00:00 GMTFDA Advisory Panel Backs Replimune's Melanoma Drug - MedscapeMedscape · Fri, 31 Jul 2026 15:17:18 GMTSecurities Fraud Investigation Into Replimune Group Inc. - GlobeNewswireGlobeNewswire · Fri, 31 Jul 2026 07:00:00 GMTReplimune stock surges on positive AdCom vote (REPL:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 03:00:59 GMT

Timeline

Fri, 07 Aug 2026 13:27:22 GMTFDA Approves Replimune Skin Cancer Drug After Rejections - Medscape
Fri, 07 Aug 2026 10:32:36 GMTReplimune Group, Inc. (REPL) Shareholder/Analyst Call - Slideshow (NASDAQ:REPL) 2026-08-07 - Seeking Alpha
Thu, 06 Aug 2026 20:46:00 GMTFDA Approves Replimune’s Melanoma Drug on Third Attempt - WSJ
Wed, 05 Aug 2026 21:52:17 GMTBragar Eagel & Squire, P.C. is Investigating Replimune - GlobeNewswire
Wed, 05 Aug 2026 00:00:00 GMTREPL SHAREHOLDER ALERT: Replimune Group Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - Business Wire
Fri, 31 Jul 2026 15:17:18 GMTFDA Advisory Panel Backs Replimune's Melanoma Drug - Medscape

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Replimune Lead Drug.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.